Rating Change
Chardan Capital analysts initiated coverage on ProMIS Neurosciences, Inc. (NASDAQ:PMN) with a Buy rating on July 27, 2026.
new coverageNASDAQ:PMN
Chardan Capital Initiates Coverage on ProMIS Neurosciences, Inc. (PMN) with Buy
Rating Change Chardan Capital analysts initiated coverage on ProMIS Neurosciences, Inc. (NASDAQ:PMN) with a Buy rating on July 27, 2026. Market Context ProMIS Neurosciences, Inc.
Market Context
ProMIS Neurosciences, Inc. operates in the Healthcare sector. The stock currently trades at $11.55 with a market capitalization of $11.3M. The stock has declined 44.5% over the past 52 weeks.
Analyst coverage from Chardan Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for ProMIS Neurosciences, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for ProMIS Neurosciences, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 27, 2026 | Chardan Capital | Buy | N/A |
| Jul 08, 2026 | Roth Capital | Buy | N/A |
| Jun 30, 2026 | Cantor Fitzgerald | Overweight | N/A |
| Jun 24, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jun 08, 2026 | HC Wainwright & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View PMN Stock Page
Frequently Asked Questions
What does a Buy rating mean for PMN?
A Buy rating from Chardan Capital reflects the analyst's outlook on ProMIS Neurosciences, Inc. (NASDAQ:PMN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PMN forecast page.